Primary objective:
To assess the neurological, neuropsychological and neuropsychiatric manifestations of COVID-19 and identify possible post-COVID neurologic, neuropsychological and neuropsychiatric syndromes at follow-up.

The secondary objectives:
To assess at 6 and 12 months´ follow-up:
The rate of stroke, peripheral nervous affection, myopathy, brain MRI pathology, level of blood specific biomarkers, rate of post-COVID-19 related cognitive and/or neuropsychiatric manifestations, the rate of death.

To assess if there is an association between inflammatory markers and
neuropsychiatry/neuropsychology, between neuroimaging and
neuropsychiatry/neuropsychology or between neurologic examination and
neuropsychiatry/neuropsychology.

More information available at: www.ous-research.no/corona